ACL injury patient ACL injury Tranexamic acid
Conditions
Interventions
Intra-articular injection of Tranexamic acid 15 mg/kg diluted with NSS up to 50 ml ,Intra-articular injection of Tranexamic acid 15 mg/kg and 0.25 mg of epinephrine diluted with NSS up to 50 ml
Experimental Drug,Active Comparator Drug
Tranexamic acid ,Tranexamic acid and Epinephrine
Sponsors
Nakornping Hospital
Eligibility
Sex/Gender
All
Age
15 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patient who underwent primary single-bundle arthroscopic ACL reconstruction using a hamstring autograft with or without meniscal surgeries in Nakornping hospital from 1st June 2021 to 31st May 2023
Exclusion criteria
Exclusion criteria: Use of other grafts Revision ACL reconstruction Concomitant knee cartilage or collateral ligament surgeries History of knee surgery on the affected knee Concomitant fracture Coagulation or bleeding disorders Preoperative anticoagulation treatment History of tranexamic acid or epinephrine allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drain output volume 24 hours postoperative ml | — |
Secondary
| Measure | Time frame |
|---|---|
| Different of hemoglobin level pre- and postoperative at 24 hours g/dL,Range of motion pre- and postoperative at 2, 6, 12 weeks Degrees,Mid patellar circumference pre- and postoperative at 2, 6, 12 weeks cm,Lysholm score pre- and postoperative at 2, 6, 12 weeks Points,International Knee Documentation Committee score pre- and postoperative at 2, 6, 12 weeks Points,Hemarthrosis grading postoperative day 3 Grade,Calf circumference postoperative day 3 cm | — |
Countries
Thailand
Contacts
Public ContactChaloemwut Piyaphattachai
Nakornping hospital
Outcome results
None listed